Hunter Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 9thDecember 2014
Summary The industry analysis specialist, has released its new report, “Hunter Syndrome Therapeutics Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Hunter Syndrome Therapeutics market. The report identifies the key trends shaping and driving the global Hunter Syndrome Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hunter Syndrome Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-hunter-syndrome-therapeutics-pipeline-assessment-and-marketforecasts-135221 Scope The report provides information on the key drivers and challenges of the Hunter Syndrome Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hunter Syndrome Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Hunter Syndrome Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hunter Syndrome Therapeutics market. - Analysis of key recent licensing and partnership agreements in Hunter Syndrome Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Hunter Syndrome Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Hunter Syndrome Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- What’s the next big thing in the global Hunter Syndrome Therapeutics market landscape? – Identify, understand and capitalize.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Hunter Syndrome Therapeutics - Introduction 2.1 Disease Overview 2.2 Epidemiology 2.2.1 Mortality 2.2.2 Race 2.2.3 Sex 2.2.4 Age 2.2.5 Quality of Life 2.3 Etiology and Pathophysiology 2.3.1 Neurological Involvement in the Hunter Syndrome 2.4 Signs and Symptoms 2.5 Diagnosis 2.5.1 Urine Glycosaminoglycans Excretion 2.5.2 Enzyme Activity 2.5.3 Gene Analysis Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.5.4 Prenatal Diagnosis 2.5.5 Diagnostic Algorithm for Hunter Syndrome 2.6 Treatment and Management Pattern 2.6.1 Disease-Specific Approaches to Manage Hunter Syndrome 2.6.2 Non-Disease-Specific Approaches to Manage Hunter Syndrome 2.7 Global Data Pipeline Report Guidance 3 Hunter Syndrome Therapeutics - Market Characterization 3.1 Hunter Syndrome Therapeutics Market Size (2006-2011) - Global 3.2 Hunter Syndrome Therapeutics Market Size (2011-2019) - Global 3.3 Hunter Syndrome Therapeutics Market Size (2006-2011) - The US 3.4 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - The US 3.5 Hunter Syndrome Therapeutics Market Size (2006-2011) - France 3.6 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - France 3.7 Hunter Syndrome Therapeutics Market Size (2006-2011) - Germany 3.8 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - Germany 3.9 Hunter Syndrome Therapeutics Market Size (2006-2011) - Italy 3.10 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - Italy 3.11 Hunter Syndrome Therapeutics Market Size (2006-2011) - Spain 3.12 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - Spain 3.13 Hunter Syndrome Therapeutics Market Size (2006-2011) - The UK 3.14 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - The UK 3.15 Hunter Syndrome Therapeutics Market Size (2006-2011) - Japan 3.16 Hunter Syndrome Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Hunter Syndrome Therapeutics Market 3.17.1 Drivers for the Hunter Syndrome Therapeutics Market 3.17.2 Barriers for the Hunter Syndrome Therapeutics Market 3.17.3 Opportunity and Unmet Need Analysis 3.18 Key Takeaway 4 Hunter Syndrome Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the Hunter Syndrome Therapeutics Market 4.3.1 Elaprase (Idursulfase) 5 Hunter Syndrome Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Hunter Syndrome Therapeutics - Pipeline by Phases of Development 5.3.1 Hunter Syndrome Therapeutics - Phase II Pipeline Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.3.2 Hunter Syndrome Therapeutics - Phase 0 Pipeline 5.3.3 Hunter Syndrome Therapeutics - Preclinical Pipeline 5.4 Hunter Syndrome Therapeutics - Pipeline by Mechanism of Action 5.5 Technology Trends Analytical Framework 5.6 Hunter Syndrome Therapeutics - Promising Drugs under Development 5.7 Molecule Profile for Promising Drugs under Clinical Development 5.7.1 HGT-2310 5.8 Key Takeaway 6 Hunter Syndrome Therapeutics - Clinical Trial Mapping 6.1 Clinical Trial Mapping Overview 6.2 Clinical Trials by Region/Country (US, EU5 and Japan) 6.3 Clinical Trials by Phase 6.4 Clinical Trials by Trial Status 6.5 Prominent Sponsors 6.6 Key Companies Participating in Therapeutics Clinical Trials 7 Hunter Syndrome Therapeutics Market - Strategic Assessment 7.1 Key Events Impacting on the Future Market 7.2 Hunter Syndrome Therapeutics: Implications for Future Market Competition 8 Hunter Syndrome Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Shire 9 Hunter Syndrome Therapeutics - Licensing and Partnership Deals 10 Hunter Syndrome Therapeutics - Appendix 10.1 Market Definitions 10.2 Abbreviations 10.3 Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 1: MPS Classification Table 2: Types of Hunter Syndrome (MPS II) Table 3: Prevalence and Incidence of Hunter Syndrome Table 4: Signs and Symptoms (Depending upon Organ/System Involved) Table 5: Urinary Glycosaminoglycans Composition in the MPS Table 6: Multidisciplinary Treatment and Management of Hunter Syndrome Table 7: Hunter Syndrome Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 8: Hunter Syndrome Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 9: Hunter Syndrome Therapeutics Market, the US, Revenue ($m), 2006-2011 Table 10: Hunter Syndrome Therapeutics Market, the US, Forecast ($m), 2011-2019 Table 11: Hunter Syndrome Therapeutics Market, France, Forecast ($m), 2006-2011 Table 12: Hunter Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019 Table 13: Hunter Syndrome Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 14: Hunter Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 15: Hunter Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 16: Hunter Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 17: Hunter Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 18: Hunter Syndrome Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 19: Hunter Syndrome Therapeutics Market, the UK, Revenue ($m), 2006-2011 Table 20: Hunter Syndrome Therapeutics Market, the UK, Forecast ($m), 2011-2019 Table 21: Hunter Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 22: Hunter Syndrome Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 23: Clinical Trial of Elaprase Table 24: Hunter Syndrome Therapeutics - Phase II Pipeline Table 25: Hunter Syndrome Therapeutics - Phase 0 Pipeline Table 26: Hunter Syndrome Therapeutics - Preclinical Pipeline Table 27: Hunter Syndrome Therapeutics- Most Promising Drugs Under Development, 2011 Table 28: Hunter Syndrome Therapeutics - Clinical Trials by Region, 2011 Table 29: Hunter Syndrome Therapeutics, Global, Clinical Trials by Phase of Development, 2011 Table 30: Hunter Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2011 Table 31: Hunter Syndrome Therapeutics Market, Global, Clinical Trials by Overall Sponsors, 2011 Table 32: Hunter Syndrome Therapeutics, Global, Clinical Trials by prominent Sponsors, 2011 Table 33: Hunter Syndrome Therapeutics, Global, Key Companies Participating Clinical Trials, 2011 Table 34: Shire - Genetic Disorder Pipeline Portfolio, 2011
List Of Figures Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 1: X-Linked Recessive Inheritance Figure 2: Signs and Symptoms of Hunter Syndrome Figure 3: Diagnostic Algorithm for Hunter Syndrome Figure 4: Hunter Syndrome Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 5: Hunter Syndrome Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 6: Hunter Syndrome Therapeutics Market, the US, Revenue ($m), 2006-2011 Figure 7: Hunter Syndrome Therapeutics Market, the US, Forecast ($m), 2011-2019 Figure 8: Hunter Syndrome Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 9: Hunter Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 10: Hunter Syndrome Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 11: Hunter Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 12: Hunter Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 13: Hunter Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 14: Hunter Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 15: Hunter Syndrome Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 16: Hunter Syndrome Therapeutics Market, the UK, Revenue ($m), 2006-2011 Figure 17: Hunter Syndrome Therapeutics Market, the UK, Forecast ($m), 2011-2019 Figure 18: Hunter Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 19: Hunter Syndrome Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 20: Opportunity and Unmet Need in the Hunter Syndrome Therapeutics Market, 2011 Figure 21: Strategic Competitor Assessment for Hunter Syndrome, 2011 Figure 22: Hunter Syndrome Therapeutics Pipeline by Phase of Development, 2011 Figure 23: Hunter Syndrome Therapeutics - Pipeline by Mechanism of Action, 2011 Figure 24: Technology Trends Analytic Framework of the Hunter Syndrome Therapeutics Pipeline, 2011 Figure 25: Technology Trends Analytic Framework of the Hunter Syndrome Therapeutics Pipeline, 2011 Figure 26: Hunter Syndrome Therapeutics - Clinical Trials by Region, 2011 Figure 27: Hunter Syndrome Therapeutics, Global, Clinical Trials by Phase of Development, 2011 Figure 28: Hunter Syndrome Therapeutics, Global, Clinical Trials by Overall Sponsors, 2011 Figure 29: Hunter Syndrome Therapeutics, Global, Clinical Trials by Prominent Sponsors, 2011 Figure 30: Hunter Syndrome Therapeutics, Global, Key Companies Participating Clinical Trials, 2011 Figure 31: Hunter Syndrome Therapeutics Market, Drivers and Barriers, 2011 Figure 32: Implications for Future Market Competition in the Hunter Syndrome Therapeutics Market, 2011
Report Price: Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019 Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Waldenstrms Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Retinoblastoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Xerostomia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Hunter Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-hunter-syndrometherapeutics-pipeline-assessment-and-market-forecasts-135221
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/